Fulcrum Therapeutics Inc (FULC)

Stock-Based Compensation

$3.27M

Quarterly · Period ending: · USD

FULC logo

FULC Stock-Based Compensation

Latest reported$3.27M
FULC Quarterly Stock-Based Comp ($429.00K → $3.27M)
High-resolution chart · PNG

FULC stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fulcrum Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
3,271,000
3,860,000
3,066,000
3,360,000
2,875,000
3,167,000
2,477,000
3,817,000
4,344,000
3,916,000
3,449,000
3,737,000
3,363,000
4,253,000
3,271,000
3,353,000
2,879,000
3,847,000
3,793,000
2,658,000
2,546,000
2,073,000
1,677,000
1,776,000
2,204,000
1,693,000
1,274,000
1,179,000
950,000
821,000
762,000
506,000
462,000
429,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.